An Open-Label, Multicenter, Phase Ib/II Study of the ATR Inhibitor SC0245 in Combination with Irinotecan in Patients with Relapsed and Refractory Extensive Stage Small Cell Lung Cancer (ES-SCLC).
JOURNAL OF CLINICAL ONCOLOGY（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要